Skip to main content
Article thumbnail
Location of Repository

Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain

By B Ojeda, L M de Sande, A Casado, P Merino and M A Casado
Topics: Clinical
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2376947
Provided by: PubMed Central

Suggested articles

Citations

  1. (1998). Using cost-minimisation analysis to select from equally effective alternatives.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.